Expression of the TRAIL receptors in blood mononuclear cells in leukemia

Pathology and Oncology Research

Volumn 13, Issue 4, 2007, Pages 290-294

  Deligezer, Ugur ^a   Dalay, Nejat ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b IU Oncology Institute   (Turkey)

Author keywords

Circulating tumor cells; Expression; Trail receptors; Translocation

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; TRAIL RECEPTOR 4; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE TRANSLOCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 39649113308     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02940307     Document Type: Article

References (21)

1. Fiorucci G, Vannucchi S, Chiantore MV, et al: TNF-related apoptosis-inducing ligand (TRAIL) as a pro-apoptotic signal transducer with cancer therapeutic potential. Curr Pharm Des 11:933-944, 2005
2. Kimberley FC, Screaton GR: Following a TRAIL: Update on a ligand and its five receptors. Cell Res 14:359-372, 2004
3. Pan G, O'Rourke K, Chinnaiyan AM, et al: The receptor for the cytotoxic ligand TRAIL. Science 276:111-113, 1997
4. Griffith TS, Chin WA, Jackson GC, et al: Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 161: 2833-2840, 1998
5. LeBlanc HN, Ashkenazi A: Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 10:66-75, 2003
6. Hasegawa H, Yamada Y, Harasawa H, et al: Restricted expression of tumor necrosis factor-related apoptosis-inducing ligand receptor 4 in human peripheral blood lymphocytes. Cell Immunol 231:1-7, 2004
7. Lum JJ, Pilon AA, Sanchez-Dardon J, et al: Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo21. J Virol 75:11128-11136, 2001
8. Daigle I, Simon HU: Alternative functions for TRAIL receptors in eosinophils and neutrophils. Swiss Med Wkly 131:231-237, 2001
9. Renshaw SA, Parmar JS, Singleton V, et al: Acceleration of human neutrophil apoptosis by TRAIL. J Immunol 170:1027-1033, 2003
10. Billadeau D, Quam L, Thomas W, et al: Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 80:1818-1824, 1992
11. Knauf WU, Pochanke G, Ho A: Detection of circulating monoclonal lymphocytes in multiple myeloma patients by analysis of gene rearrangements: correlation with progressive disease. Leuk Res 7:341-345, 1993
12. Rawstron AC, Owen RG, Davies FE, et al: Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol 97:46-55, 1997
13. Zojer N, Schuster-Kolbe J, Assmann I, et al: Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance. Br J Haematol 117:852-859, 2002
14. Deligezer U, Erten N, Akisik EE, et al: Circulating fragmented microsomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma. Exp Mol Pathol 80:72-76, 2006
15. Griffith TS, Wiley SR, Kubin MZ, et al: Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med 189:1343-1354, 1999
16. Inoue H, Shiraki K, Yamanaka T, et al: Functional expression of tumor necrosis factor-related apoptosis-inducing ligand in human colonic adenocarcinoma cells. Lab Invest 82:1111-1119, 2002
17. Janicke RU, Sprengart ML, Wati MR, et al: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273:9357-9360, 1998
18. van Dongen JJ, Macintyre EA, Gabert JA, et al: Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 13:1901-1928, 1999
19. Narita M, Takahashi M, Liu A, et al: Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia.Exp Hematol 26:709-719, 2001
20. MacFarlane M, Kohlhaas SL, Sutcliffe MJ, et al: TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies. Cancer Res 65:11265-11270, 2005
21. Kaufmann SH, Steensma DP: On the TRAIL of a new therapy for leukemia. Leukemia 19:2195-2202, 2005